Aptus Pharma Limited — Major Shareholding Notification 2026

May 14, 2026

CHATRABHUJ VALLABHBHAI BUTANI

Address: Giriraj Jyotinagar Str No-1 BH Crystal Mall Kalavad Road, Rajkot-360005, Gujarat

To,

BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai – 400001

Dear Sir,

Sub.: Disclosure under Regulation 29 of SEBI Regulation, 2011 (Substantial Acquisition of Shares and Takeover)

Ref.: Name- APTUS PHARMA LIMITED (iNE15XJ01010) – CODE - APPL

With reference to the subject matter, enclosed herewith please find the details of Sell of Shares of Aptus Pharma Limited in term of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 2011 on 11th May, 2026.

Kindly take the same on your records and acknowledge the receipt.

Chatrabhuj Vallabhbhai Butani

Date: 13.05.2026
Place: Rajkot

---

Disclosures under Regulation 29(1) of Securities and Exchange Board of India(Substantial Acquisition of Shares and Takeovers) Regulations, 2011

To,
BSE Limited
Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

Aptus Pharma Limited
Attn: The Compliance Officer

Sub: Disclosure under Regulation 29(1) / 29(2) of the SEBI (SAST) Regulations, 2011 — Acquisition of equity shares of Aptus Pharma Limited (Scrip Code: 544529; ISIN: INE15XJ01010)

Part-A- Details of the Acquisition

Name of the Target Company (TC)	Aptus Pharma Limited
Name(s) of the acquirer/Seller and Persons Acting in Concert (PAC) with the acquirer/Seller	Mr. Chatrabhuj Vallabhbhai Butani (Promotor / Promotor Group)
Whether the acquirer/ Seller belongs to Promoter/Promotergroup	Yes
Name(s) of the Stock Exchange(s) where the shares of TC are Listed	BSE Limited (SME)
Details of the acquisition/ disposal as follows	Number	% w.r.t. total share/voting capital wherever applicable (*)	% w.r.t. total diluted share/voting capital of the TC (**)
Before the acquisition/disposal under consideration, holding of acquirer along with PACs of:
a) Shares carrying voting rights	2,25,000	3.28%	0
b) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/others)
c) Voting rights (VR) otherwise than by equity shares
d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category)
e) Total (a+b+c+d)	2,25,000	3.28%	0

---

Details of acquisition/ Sale
a) Shares carrying voting rights acquired
b) VRs acquired otherwise than by
equity shares
c) Warrants/convertible securities/any
other instrument that entitles the
acquirer to receive shares carrying
category acquired
d) Shares in the nature of
encumbrance (pledge/ lien/ non-
disposal undertaking/others)
e) Total (a+b+c+d+/-d)	1,24,000
1,24,000	1.81%
1.81%	0
0
After the acquisition, Sale, holding of along
with PACs of:
a) Shares carrying voting rights
b) VRs otherwise than by equity shares
c) Warrants/convertible securities/any
other instrument that entitles the
acquirer to receive shares carrying
voting rights in the TC (specify holding
in each category) after acquisition
d) Shares in the nature of
encumbrance (pledge/ lien/ non-
disposal undertaking/others)
e) Total (a+b+c+d)	1,01,000
1,01,000	1.47%
1.47%	0
0
Mode of acquisition / Sale (e.g. open market-/
public issue / rights issue / preferential
allotment / inter-set transfer/encumbrance, etc.)	Off-market inter-se transfer among Promoter
Group
Salient features of the securities acquired
including time till redemption, ratio at which it
can be converted into equity shares, etc.	NA
Date of acquisition of/ Sale of Shares/ date of
receipt of intimation of allotment of shares /
VR/ warrants/convertible securities/any other
instrument that entitles the acquirer to receive
shares in the TC.	11.05.2026
Equity share capital / total voting capital of
the TC before the said acquisition	68,60,000 equity shares of Rs. 10/-
Equity share capital/ total voting capital of the
TC after the said acquisition	68,60,000 equity shares of Rs. 10/-
Total diluted share/voting capital of the TC
after thesaid acquisition	68,60,000 equity shares of Rs. 10/-